Dashboard E. coli
Repurposing candidates for E. coli
Escherichia coli
Approved medicines with AI-predicted activity ≥40% against E. coli, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 467
- Existing antimicrobials set aside
- 103
- Needing review
- 28
- Repurposing candidates
- 336
Repurposing candidates for E. coli
AI prediction · nothing measuredAll 336 repurposing candidates for E. coli.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- ElbasvirExisting use: Chronic hepatitis C virus infection, Viral disease44.9% AI-predicted activityagainst E. coli50+ registered studies
- AnidulafunginExisting use: Candidemia, Candidiasis, Peritonitis44.9% AI-predicted activityagainst E. coli43 registered studies
- Nicardipine HydrochlorideExisting use: Cardiovascular disease, Hypertension44.8% AI-predicted activityagainst E. coli50+ registered studies
- HaloperidolExisting use: Conduct disorder, Mental or behavioural disorder, Psychosis and 4 more44.8% AI-predicted activityagainst E. coli50+ registered studies
- ReserpineExisting use: Hypertension44.7% AI-predicted activityagainst E. coli10 registered studies
- EncorafenibExisting use: Cancer, Colorectal adenocarcinoma, Colorectal cancer and 5 more44.6% AI-predicted activityagainst E. coli50+ registered studies
- Naloxegol OxalateExisting use: Constipation, Constipation disorder, Opioid dependence and 1 more44.5% AI-predicted activityagainst E. coli2 registered studies
- CabazitaxelExisting use: Cancer, Metastatic prostate cancer, Neoplasm and 4 more44.5% AI-predicted activityagainst E. coli50+ registered studies
- Fludarabine PhosphateExisting use: Cancer, Chronic lymphocytic leukemia, Neoplasm44.5% AI-predicted activityagainst E. coli50+ registered studies
- Afatinib DimaleateExisting use: Non-small cell lung carcinoma44.4% AI-predicted activityagainst E. coli50+ registered studies
- DarunavirExisting use: HIV infection, HIV-1 infection, Immunodeficiency disease and 2 more44.4% AI-predicted activityagainst E. coli50+ registered studies
- CapivasertibExisting use: Breast cancer, Breast neoplasm, Cancer and 1 more44.3% AI-predicted activityagainst E. coli50+ registered studies
- Flavoxate HydrochlorideExisting use: Dysuria, Prostatitis, Urethritis and 1 more44.3% AI-predicted activityagainst E. coli2 registered studies
- LoxapineExisting use: Agitation, Bipolar disorder, Bipolar I disorder and 2 more44.3% AI-predicted activityagainst E. coli37 registered studies
- PaclitaxelExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 13 more44.2% AI-predicted activityagainst E. coli50+ registered studies
- LifitegrastExisting use: Dry eye syndrome, Eye disease44.2% AI-predicted activityagainst E. coli39 registered studies
- AlvimopanExisting use: Constipation44.2% AI-predicted activityagainst E. coli26 registered studies
- TovorafenibExisting use: Low grade glioma44.1% AI-predicted activityagainst E. coli16 registered studies
- BuprenorphineExisting use: Chronic pain, Drug dependence, Opioid dependence and 4 more44.1% AI-predicted activityagainst E. coli50+ registered studies
- Conivaptan HydrochlorideExisting use: Cardiovascular disease, Heart failure44.1% AI-predicted activityagainst E. coli21 registered studies
- DacomitinibExisting use: Neoplasm, Non-small cell lung carcinoma44.1% AI-predicted activityagainst E. coli50+ registered studies
- CeritinibExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma44.0% AI-predicted activityagainst E. coli50+ registered studies
- FezolinetantExisting use: Hot flashes44.0% AI-predicted activityagainst E. coli32 registered studies
- TolvaptanExisting use: Autosomal dominant polycystic kidney disease, Cardiovascular disease, Congestive heart failure and 4 more44.0% AI-predicted activityagainst E. coli50+ registered studies